COVID-19 and Rheumatic Diseases: Practical Issues
On March 12, 2020, the World Health Organization (WHO) declared coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) a pandemic. The rapidly increasing number of cases and deaths have overwhelmed the health care system worldwide. We aimed to...
Main Authors: | Ho So, Chi Chiu Mok |
---|---|
Format: | Article |
Language: | English |
Published: |
World Scientific Publishing
2020-07-01
|
Series: | Journal of Clinical Rheumatology and Immunology |
Subjects: | |
Online Access: | http://www.worldscientific.com/doi/epdf/10.1142/S2661341720300025 |
Similar Items
-
Do all patients with rheumatic Diseases have a higher risk of COVID 19? Initial results from the Karnataka Rheumatology Association COVID 19 Cohort Study (KRACC)
by: Vineeta Shobha, et al.
Published: (2021-01-01) -
Autoimmune and Rheumatic Manifestations Associated With COVID-19 in Adults: An Updated Systematic Review
by: Kuo-Tung Tang, et al.
Published: (2021-03-01) -
Rheumatic Musculoskeletal Diseases and COVID-19 A Review of the First 6 Months of the Pandemic
by: Martin H. Stradner, et al.
Published: (2020-10-01) -
COVID‐19 infection in patients with connective tissue disease: A multicity study in Hubei province, China
by: Cong Ye, et al.
Published: (2021-03-01) -
Anti-rheumatic in SARS-CoV-2: benefit or risk?
by: Francesco Ferrara
Published: (2020-04-01)